Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
Titel:
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
Auteur:
Ciardiello, F. Normanno, N. Martinelli, E. Troiani, T. Pisconti, S. Cardone, C. Nappi, A. Bordonaro, A.R. Rachiglio, M. Lambiase, M. Latiano, T.P. Modoni, G. Cordio, S. Giuliani, F. Biglietto, M. Montesarchio, V. Barone, C. Tonini, G. Cinieri, S. Febbraro, A. Rizzi, D. De Vita, F. Orditura, M. Colucci, G. Maiello, E.